Source: Blood. Conference titles: Annual Meeting of the American Society of Hematology. Unidade: FM
Assunto: HEMATOLOGIA
ABNT
PALLOTTA-FILHO, R. S. et al. The use of mycophenolate mofetil in the treatment of refractory chronic graft versus host disease. Blood. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 25 ago. 2024. , 1998APA
Pallotta-Filho, R. S., Barbosa, J. A. L., Macedo, M. C. M. A., Saboya, R., Silva, R. L., Jamra, M., et al. (1998). The use of mycophenolate mofetil in the treatment of refractory chronic graft versus host disease. Blood. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.NLM
Pallotta-Filho RS, Barbosa JAL, Macedo MCMA, Saboya R, Silva RL, Jamra M, Chamone D de AF, Dulley FL. The use of mycophenolate mofetil in the treatment of refractory chronic graft versus host disease. Blood. 1998 ; 92( 10): 346b.[citado 2024 ago. 25 ]Vancouver
Pallotta-Filho RS, Barbosa JAL, Macedo MCMA, Saboya R, Silva RL, Jamra M, Chamone D de AF, Dulley FL. The use of mycophenolate mofetil in the treatment of refractory chronic graft versus host disease. Blood. 1998 ; 92( 10): 346b.[citado 2024 ago. 25 ]